Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 293 results found. Search for [ Glenmark Pharma ]

Results 1 to 21 of 293
E Kumar Sharma
New Delhi, December 10, 2019
Diabetes drug price: Companies are talking of a significant price cut. Intas Pharmaceuticals, according to a senior official in the company, will hit the market today with two versions


PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


Joe C Mathew
New Delhi, October 30, 2019
The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight


BusinessToday.In
October 30, 2019
Ajanta Pharma share price which stood at Rs 12.41 on October 30, 2009 has risen to Rs 1,020 during the period.


PTI
October 9, 2019



PTI
October 7, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


PTI
October 7, 2019



BusinessToday.In
New Delhi, September 28, 2019
As per the proposal, Glenmark Pharma plans to raise up to $200 million in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches


PTI
September 10, 2019



PTI
August 24, 2019



PTI
August 19, 2019



Joe C Mathew
New Delhi, July 24, 2019
Kemwell will take a minority stake in Stempeutics and invest up to Rs 95 crore based on certain milestones as well as establish a world class cGMP cell therapy manufacturing  facility  at  Kemwell's  facility  in  Bengaluru.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


BusinessToday.In
New Delhi, July 11, 2019
As per the agreement, Glenmark will receive an upfront payment, licence fees and royalties for the non-exclusive sub-license rights from Torrent


PTI
July 11, 2019



PTI
July 11, 2019



PTI
June 28, 2019



BusinessToday.In
June 24, 2019
Glenmark Pharma's shares opened 5 points down at Rs 495 after forming a gap down chart pattern at the opening bell, against the last close of Rs 500


PAGES 1 OF 15  12345